Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin in Patient at High Risk of Bleeding Undergoing Percutaneous Coronary Interventions.

NCT01465503 is registered in ClinicalTrials.gov with Clinica Mediterranea as lead sponsor.

NCT NCT01465503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01465503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin in Patient at High Risk of Bleeding Undergoing Percutaneous Coronary Interventions.
Lead sponsor
Clinica Mediterranea
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2013
Enrollment
837 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding